SCHEMBL3873560

SCHEMBL3873560

CC(C)N1CCN(c2cc(-c3ccccc3C(F)(F)F)nc(C#N)n2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.54
CYP1A2 P05177 6/20 0.48
CYP2C19 P33261 4/20 0.48
CTSS P25774 3/20 0.43
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 3/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CNR2 P34972 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
DRD2 P14416 1/20 0.39
HTR6 P50406 1/20 0.39
ACP1 P24666 2/20 0.37
TRPA1 O75762 1/20 0.36
CYP2C9 P11712 1/20 0.36
NSD2 O96028 1/20 0.36
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3879138 0.93 CTSK (0.48) CTSKCYP1A2CYP2C19CTSSCYP3A4
SCHEMBL3873575 0.83 CTSK (0.51) CTSKCYP1A2CYP2C19CTSSCYP3A4
Hydrochloric Acid SCHEMBL3885789 0.82 CTSK (0.50) CTSKCYP1A2CYP2C19CTSSCYP3A4
SCHEMBL3873562 0.81 CTSK (0.52) CTSKCTSSCYP3A4CYP2D6HRH3
SCHEMBL3875249 0.81 CTSK (0.51) CTSKCYP1A2CYP2C19CTSSCYP3A4
Trifluoroacetic Acid SCHEMBL3882810 0.75 CTSK (0.46) CTSKCYP1A2CYP2C19CTSSCYP3A4
Trifluoroacetic Acid SCHEMBL27718837 0.75 CTSK (0.46) CTSKCTSSCYP3A4CYP2D6HRH3
SCHEMBL4440664 0.70 CTSK (1.00) CTSKCTSS
SCHEMBL13648779 0.67 HRH3 (0.58) CYP1A2CYP2C19CYP3A4CYP2D6KDM4E
SCHEMBL13898878 0.67 AKR1C3 (0.50) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928842-B1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2009-11-18 EP claimed
EP-1928842-A1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2008-06-11 EP claimed
US-7326715-B2 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2008-02-05 US claimed
US-20070111992-A1 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2007-05-17 US claimed
WO-2007039470-A1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2007-04-12 WO claimed
EP-1928842-B1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2009-11-18 EP disclosed
EP-1928842-A1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2008-06-11 EP disclosed
US-7326715-B2 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2008-02-05 US disclosed
US-20070111992-A1 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2007-05-17 US disclosed
WO-2007039470-A1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111992-A1 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives CTSK, CTSS, CTSF CTSK 1/4885CYP1A2 2048/4885CYP2C19 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.